These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1985582)

  • 1. Amiodarone versus bretylium for suppression of reperfusion arrhythmias in dogs.
    Rosalion A; Snow NJ; Horrigan TP; Noon DL; Mostow ND
    Ann Thorac Surg; 1991 Jan; 51(1):81-5. PubMed ID: 1985582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of chronic canine ventricular tachyarrhythmias with bretylium tosylate.
    Patterson E; Gibson JK
    Circulation; 1981 Nov; 64(5):1045-50. PubMed ID: 7285294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone and bretylium in the treatment of hypothermic ventricular fibrillation in a canine model.
    Stoner J; Martin G; O'Mara K; Ehlers J; Tomlanovich M
    Acad Emerg Med; 2003 Mar; 10(3):187-91. PubMed ID: 12615580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of bretylium to suppress inducible ventricular tachycardia.
    Greene HL; Werner JA; Gross BW; Sears GK
    Am Heart J; 1983 May; 105(5):717-21. PubMed ID: 6846114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ischemia-induced conduction delay and ventricular arrhythmias: comparative electropharmacology of bethanidine sulfate and bretylium tosylate.
    Kabell G
    J Cardiovasc Pharmacol; 1989 Mar; 13(3):471-82. PubMed ID: 2471895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A method for quantitating antifibrillatory effects of drugs after coronary reperfusion in dogs: improved outcome with bretylium.
    Wenger TL; Lederman S; Starmer CF; Brown T; Strauss HC
    Circulation; 1984 Jan; 69(1):142-8. PubMed ID: 6689638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of ventricular fibrillation by bretylium in a conscious canine model of sudden coronary death.
    Holland K; Patterson E; Lucchesi BR
    Am Heart J; 1983 May; 105(5):711-7. PubMed ID: 6846113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of bretylium on experimental cardiac dysrhythmias.
    Allen JD; Zaidi SA; Shanks RG; Pantridge JF
    Am J Cardiol; 1972 May; 29(5):641-9. PubMed ID: 5021494
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiarrhythmic properties of a prior oral loading of amiodarone in in vivo canine coronary ligation/reperfusion-induced arrhythmia model: comparison with other class III antiarrhythmic drugs.
    Nagasawa Y; Chen J; Hashimoto K
    J Pharmacol Sci; 2005 Mar; 97(3):393-9. PubMed ID: 15764841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemia- and reperfusion-induced ventricular arrhythmias in dogs: effects of estrogen.
    McHugh NA; Cook SM; Schairer JL; Bidgoli MM; Merrill GF
    Am J Physiol; 1995 Jun; 268(6 Pt 2):H2569-73. PubMed ID: 7611507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group.
    Kowey PR; Levine JH; Herre JM; Pacifico A; Lindsay BD; Plumb VJ; Janosik DL; Kopelman HA; Scheinman MM
    Circulation; 1995 Dec; 92(11):3255-63. PubMed ID: 7586312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of bretylium tosylate on the prevention and treatment of postoperative arrhythmias.
    Castaneda AR; Bacaner MB
    Am J Cardiol; 1970 Apr; 25(4):461-6. PubMed ID: 5438242
    [No Abstract]   [Full Text] [Related]  

  • 13. The antiarrhythmic and antifibrillatory actions of bretylium and its o-iodobenzyl trimethylammonium analog, UM-360.
    Kniffen FJ; Lomas TE; Counsell RE; Lucchesi BR
    J Pharmacol Exp Ther; 1975 Jan; 192(1):120-8. PubMed ID: 1123718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale of therapy in the patient with acute myocardial infarction and life-threatening arrhythmias: a focus on bretylium.
    Lucchesi BR
    Am J Cardiol; 1984 Jul; 54(2):14A-19A. PubMed ID: 6380259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic treatment of swine with bretylium for experimental cardiac catheterization.
    Schumann RE; Harold ME; Gillette PC; Swindle MM; Gaymes CH
    Lab Anim Sci; 1993 Jun; 43(3):244-6. PubMed ID: 8355485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiologic effects of bretylium tosylate on the canine heart during coronary artery occlusion and reperfusion.
    Gibson JK; Stewart JR; Li YP; Lucchesi BR
    J Cardiovasc Pharmacol; 1983; 5(4):517-24. PubMed ID: 6193345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bretylium tosylate: a newly available antiarrhythmic drug for ventricular arrhythmias.
    Heissenbuttel RH; Bigger JT
    Ann Intern Med; 1979 Aug; 91(2):229-38. PubMed ID: 380436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmias induced by myocardial ischaemia-reperfusion are sensitive to ionotropic excitatory amino acid receptor antagonists.
    D'Amico M; Di Filippo C; Rossi F; Rossi F
    Eur J Pharmacol; 1999 Feb; 366(2-3):167-74. PubMed ID: 10082197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradoxical ventricular tachycardia and fibrillation after intravenous bretylium therapy. Report of two cases.
    Anderson JL; Popat KD; Pitt B
    Arch Intern Med; 1981 May; 141(6):801-2. PubMed ID: 7235792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of bupivacaine-induced cardiac arrhythmias in hypoxic and hypercarbic pigs with amiodarone or bretylium.
    Haasio J; Pitkänen MT; Kyttä J; Rosenberg PH
    Reg Anesth; 1990; 15(4):174-9. PubMed ID: 2073482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.